In-Med Prognostics Profile Photo

In-Med Prognostics

(PROGNOSTICS IN-MED PRIVATE LIMITED)

1 Published Patent

Founded in 2018

About In-Med Prognostics

In-Med Prognostics is a startup that provides an AI-based neurology workflow platform. It offers a neurology workflow software and the neuroShield platform that provides reports, brain scan analysis, radiologist man hours, and healthcare resource utilisation. It also offers VivoShield Sports, which offers sports-specific body assessment and tissue distribution profiling.

Key Founders and Directors of In-Med Prognostics

Key Focus Areas of In-Med Prognostics

Brain Volumetry +4 more focus areas

Angel Networks & VC Investors of In-Med Prognostics

Frequently Asked Questions (FAQ)

When was In-Med Prognostics founded?

In-Med Prognostics was founded in the year 2018.

What is the legal name of In-Med Prognostics?

The legal name of In-Med Prognostics is Prognostics In-med Private Limited.

Who are the founders of In-Med Prognostics?

In-Med Prognostics is founded by Latha Chandrasekaran Poonamallee

Which VC Investors & Angel Networks funded In-Med Prognostics?

In-Med Prognostics is funded by Exxora.

Which Incubators & Accelerators supported In-Med Prognostics?

In-Med Prognostics is supported by Incubators & Accelerators like Centre Of Innovation And Entrepreneurship (Cie), Iiit Hyderabad and 2 others.

What are the focus areas of In-Med Prognostics?

The key focus areas of In-Med Prognostics are Brain Volumetry and 4 others.

Who are In-Med Prognostics's competitors?

Possible competitors of In-Med Prognostics may include Aarca Research, Adiuvo Diagnostics, Beyondtech It Solutions and 7 others.

Get Access to Complete Information

Signup Now

YNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits